- Home
- HFFG vs LYEL Comparison
HFFG vs LYEL Comparison
Compare HFFG & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- LYEL
- Stock Information
- Founded
- HFFG 1997
- LYEL 2018
- Country
- HFFG United States
- LYEL United States
- Employees
- HFFG N/A
- LYEL N/A
- Industry
- HFFG Food Distributors
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- HFFG Consumer Discretionary
- LYEL Health Care
- Exchange
- HFFG Nasdaq
- LYEL Nasdaq
- Market Cap
- HFFG 208.3M
- LYEL 207.7M
- IPO Year
- HFFG N/A
- LYEL 2021
- Fundamental
- Price
- HFFG $2.67
- LYEL $11.02
- Analyst Decision
- HFFG
- LYEL Sell
- Analyst Count
- HFFG 0
- LYEL 2
- Target Price
- HFFG N/A
- LYEL $15.00
- AVG Volume (30 Days)
- HFFG 69.1K
- LYEL 73.6K
- Earning Date
- HFFG 08-11-2025
- LYEL 08-11-2025
- Dividend Yield
- HFFG N/A
- LYEL N/A
- EPS Growth
- HFFG N/A
- LYEL N/A
- EPS
- HFFG N/A
- LYEL N/A
- Revenue
- HFFG $1,204,441,000.00
- LYEL $65,000.00
- Revenue This Year
- HFFG $4.27
- LYEL N/A
- Revenue Next Year
- HFFG $4.47
- LYEL N/A
- P/E Ratio
- HFFG N/A
- LYEL N/A
- Revenue Growth
- HFFG 4.71
- LYEL N/A
- 52 Week Low
- HFFG $1.70
- LYEL $7.65
- 52 Week High
- HFFG $4.93
- LYEL $32.60
- Technical
- Relative Strength Index (RSI)
- HFFG 25.92
- LYEL 52.37
- Support Level
- HFFG $2.64
- LYEL $9.11
- Resistance Level
- HFFG $3.07
- LYEL $14.18
- Average True Range (ATR)
- HFFG 0.16
- LYEL 0.94
- MACD
- HFFG -0.03
- LYEL 0.15
- Stochastic Oscillator
- HFFG 11.11
- LYEL 38.68
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.